Skip to content
Showing 1 - 10 of 1623 results.
“If you can’t clear the virus quickly enough, you’re susceptible to damage from the virus and the immune system,” says Donna Farber, a microbiologist at Columbia.
Steroids like dexamethasone, on the other hand, are like “big hammers” that can curb the activity of multiple cytokines at once, Dr. Farber said.
“This bodes well for the Phase 3 trials,” said Dr. Angela Rasmussen, a virologist at Columbia University who was not involved in the study.
Dr. Tsion Firew, an emergency physician at Columbia University who wasn’t involved in the work, cautioned that the links between masking and milder disease haven’t yet been proved as cause and effect.
“It’s reducing the risk, not eliminating the risk,” said Wafaa El-Sadr, a professor of epidemiology and medicine at Columbia University’s Mailman School of Public Health.
Dr. David Ho, scientific director and CEO of the Aaron Diamond AIDS Research Center, talks with Rachel Maddow about using antibodies from COVID-19 survivors against new coronavirus infections.
“People, depending on their ideology on school opening, are choosing which evidence to present — and that needs to be avoided,” said Jeffrey Shaman, an epidemiologist at Columbia University.
“We have to find a balance between preserving safety and living,” said Dr. Linda Fried, a geriatrician and the dean of the Mailman School of Public Health at Columbia University.
Editor's Note: Center for Radiological Research director David Brenner describes the experiment that showed the promise of far-UVC light as a potential coronavirus killer.
“I don’t anticipate that New York will have a second wave like what we have in Texas and Florida,” said Ian Lipkin, director of the Center for Infection and Immunity at Columbia University.